Catherijne A J Knibbe (Catherijne A Knibbe, Catherijne Aj Knibbe, C A J Knibbe)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 37

Top Topics

Bariatric Surgery

Top Venues

Clinical pharmacokinetics

The AAPS journal

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Tan Zhang, Elisa A M Calvier, Elke H J Krekels, Catherijne A J Knibbe
Impact of Obesity on Hepatic Drug Clearance: What are the Influential Variables? The AAPS journal 26 (3) (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics 63 (1) (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics 63 (1) (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics 63 (1) (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics 63 (1) (2024)
Koen P van Rhee, Catherijne A J Knibbe, P D van der Linden, Roger J M Brüggemann
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action. Clinical pharmacokinetics (2024)
Tan Zhang, Elisa A M Calvier, Elke H J Krekels, Catherijne A J Knibbe
Impact of Obesity on Hepatic Drug Clearance: What are the Influential Variables? The AAPS journal 26 (3) (2024)
Tan Zhang, Elisa A M Calvier, Elke H J Krekels, Catherijne A J Knibbe
Impact of Obesity on Hepatic Drug Clearance: What are the Influential Variables? The AAPS journal 26 (3) (2024)
Lianne J Stevens, Jeroen Dubbeld, Jason B Doppenberg, Bart van Hoek, Aswin L Menke, Joanne M Donkers, Abdulnaser Alsharaa, Arjan de Vries, Wouter H J Vaes, Catherijne A J Knibbe, Evita van de Steeg, Ian P J Alwayn
Novel explanted human liver model to assess hepatic extraction, biliary excretion and transporter function. Clinical pharmacology and therapeutics (2023)
Tan Zhang, Elke H J Krekels, Cornelis Smit, Eric P A van Dongen, Roger J M Brüggemann, Catherijne A J Knibbe
How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400-600 mg·h/L-Targeted Dosing. Clinical pharmacokinetics (2023)
Lu Chen, Elke H J Krekels, Anne R Heijnen, Catherijne A J Knibbe, Roger J M Brüggemann
An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers. Drugs 83 (1) (2023)
Laura B Zwep, Tingjie Guo, Thomas Nagler, Catherijne A J Knibbe, Jacqueline J Meulman, Johan G C van Hasselt
Virtual patient simulation using copula modeling. Clinical pharmacology and therapeutics (2023)
Lu Chen, Elke H J Krekels, Anne R Heijnen, Catherijne A J Knibbe, Roger J M Brüggemann
An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers. Drugs 83 (1) (2023)
Lu Chen, Elke H J Krekels, Anne R Heijnen, Catherijne A J Knibbe, Roger J M Brüggemann
An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers. Drugs (2023)
Yunjiao Wu, Swantje Völler, Elke H J Krekels, Daniëlla W E Roofthooft, Sinno H P Simons, Dick Tibboel, Robert B Flint, Catherijne A J Knibbe
Maturation of Paracetamol Elimination Routes in Preterm Neonates Born Below 32 Weeks of Gestation. Pharmaceutical research (2023)
Tan Zhang, Cornelis Smit, Catherine M T Sherwin, Catherijne A J Knibbe, Elke H J Krekels
Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents. Clinical pharmacokinetics (2023)
Lu Chen, Elke H J Krekels, Anne R Heijnen, Catherijne A J Knibbe, Roger J M Brüggemann
An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers. Drugs 83 (1) (2023)
Britta C Arends, Heleen J Blussé van Oud-Alblas, Lisette M Vernooij, Lisa Verwijmeren, Douwe H Biesma, Catherijne A J Knibbe, Peter G Noordzij, Eric P A van Dongen
The association of polypharmacy with functional decline in elderly patients undergoing cardiac surgery. British journal of clinical pharmacology 88 (5) (2022)
Naïm Bouazza, Aristides Dokoumetzidis, Catherijne A J Knibbe, Saskia N de Wildt, Claire Ambery, Pieter A De Cock, Elke Gasthuys, Frantz Foissac, Saïk Urien, Anna-Karin Hamberg, Italo Poggesi, Wei Zhao, An Vermeulen, Joseph F Standing, Jean Marc Treluyer, null null
General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children. British journal of clinical pharmacology 88 (12) (2022)
Koen P van Rhee, Cornelis Smit, Roeland E Wasmann, Paul D van der Linden, Marinus J Wiezer, Eric P A Van Dongen, Elke H J Krekels, Roger J M Brüggemann, Catherijne A J Knibbe
Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study. Clinical pharmacokinetics 61 (8) (2022)
K P van Rhee, S L de Vroom, R M van Hest, P D van der Linden, S H Tonino, E Molendijk, R A A Mathôt, N M A Blijlevens, Catherijne A J Knibbe, Roger J M Brüggemann, S E Geerlings
Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies. The Journal of antimicrobial chemotherapy 77 (11) (2022)
Willemieke G van Braak, Jeroen E H Ponten, Charlotte S Loozen, Judith P M Schots, Anna A W van Geloven, Sandra C Donkervoort, Grard A P Nieuwenhuijzen, Marc G Besselink, Tjarda N T van Heek, Philip R de Reuver, Bart Vlaminckx, Johannes C Kelder, Catherijne A J Knibbe, Hjalmar C van Santvoort, Djamila Boerma
Antibiotic prophylaxis for acute cholecystectomy: PEANUTS II multicentre randomized non-inferiority clinical trial. The British journal of surgery 109 (3) (2022)
Lu Chen, Koen P van Rhee, Roeland E Wasmann, Elke H J Krekels, Marinus J Wiezer, Eric P A van Dongen, Paul E Verweij, Paul D van der Linden, Roger J M Brüggemann, Catherijne A J Knibbe
Total bodyweight and sex both drive pharmacokinetic variability of fluconazole in obese adults. The Journal of antimicrobial chemotherapy 77 (8) (2022)
Stan J F Hartman, Parth J Upadhyay, Ron A A Mathôt, Michiel van der Flier, Michiel F Schreuder, Roger J M Brüggemann, Catherijne A J Knibbe, Saskia N de Wildt
Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children. The Journal of antimicrobial chemotherapy 77 (6) (2022)
Sebastiaan C Goulooze, Erwin Ista, Monique van Dijk, Dick Tibboel, Elke H J Krekels, Catherijne A J Knibbe
Towards Evidence-Based Weaning: a Mechanism-Based Pharmacometric Model to Characterize Iatrogenic Withdrawal Syndrome in Critically Ill Children. The AAPS journal 23 (4) (2021)
Yunjiao Wu, Swantje Völler, Robert B Flint, Sinno H P Simons, Karel Allegaert, Vineta Fellman, Catherijne A J Knibbe
Pre- and Postnatal Maturation are Important for Fentanyl Exposure in Preterm and Term Newborns: A Pooled Population Pharmacokinetic Study. Clinical pharmacokinetics (2021)
Jurjen S Kingma, Desirée M T Burgers, Valerie M Monpellier, Marinus J Wiezer, Heleen J Blussé van Oud-Alblas, Janelle D Vaughns, Catherine M T Sherwin, Catherijne A J Knibbe
Oral drug dosing following bariatric surgery: General concepts and specific dosing advice. British journal of clinical pharmacology (2021)
Cornelis Smit, Roeland E Wasmann, Marinus J Wiezer, Hendricus P A van Dongen, Johan W Mouton, Roger J M Brüggemann, Catherijne A J Knibbe
Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study. Pharmaceutical research 37 (2) (2020)
Cornelis Smit, Mariska Y M Peeters, Johannes N van den Anker, Catherijne A J Knibbe
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties. Clinical pharmacokinetics 59 (6) (2020)
Lu Chen, Elke H J Krekels, Paul E Verweij, Jochem B Buil, Catherijne A J Knibbe, Roger J M Brüggemann
Pharmacokinetics and Pharmacodynamics of Posaconazole. Drugs 80 (7) (2020)
Cornelis Smit, Roeland E Wasmann, Sebastiaan Camiel Goulooze, Marinus J Wiezer, Eric P A van Dongen, Johan W Mouton, Roger J M Brüggemann, Catherijne A J Knibbe
Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals. British journal of clinical pharmacology 86 (2) (2020)
Cornelis Smit, Roeland E Wasmann, Marinus J Wiezer, Hendricus P A van Dongen, Johan W Mouton, Roger J M Brüggemann, Catherijne A J Knibbe
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study. Pharmaceutical research 36 (8) (2019)
Y E Lentferink, Catherijne A J Knibbe, Marja M J van der Vorst
Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review. Drugs 78 (18) (2019)
E A M Calvier, E H J Krekels, T N Johnson, A Rostami-Hodjegan, D Tibboel, Catherijne A J Knibbe
Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method. The AAPS journal 21 (3) (2019)
Sebastiaan C Goulooze, Elke H J Krekels, Thomas Hankemeier, Catherijne A J Knibbe
Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools. The AAPS journal 21 (1) (2018)
Elisa A M Calvier, Thu Thuy Nguyen, Trevor N Johnson, Amin Rostami-Hodjegan, Dick Tibboel, Elke H J Krekels, Catherijne A J Knibbe
Can Population Modelling Principles be Used to Identify Key PBPK Parameters for Paediatric Clearance Predictions? An Innovative Application of Optimal Design Theory. Pharmaceutical research 35 (11) (2018)
Rosa T van der Kaaij, Hidde Jw Braam, Henk Boot, Maartje Los, Annemieke Cats, Cecile Grootscholten, Jan H M Schellens, Arend Gj Aalbers, Alwin D R Huitema, Catherijne A J Knibbe, Djamila Boerma, Marinus J Wiezer, Bert van Ramshorst, Johanna W van Sandick
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. JMIR research protocols 6 (7) (2017)